PARI products are used in more clinical trials to prove safety and efficacy of new medications compared to any other brand.
Clinical Partners: Ask us how we can help you deliver your medication faster and more effectively.
PARI’s expertise in aerosol science, superior device performance and proven track record with clinical trials provides pharmaceutical companies with innovative and effective solutions for inhaled drug delivery. PARI continues to innovate by offering novel marketing solutions for product launches and promotions. These programs are designed to meet the unique needs of pharmaceutical companies from early experimental phases to commercialization.
In addition, PARI products are currently being used in more than 20 clinical trials for new medications delivered by nebulizer. PARI is a proven partner with the following pharmaceutical companies; our products are listed in the package insert for many medications including those indicated (*) below:
- Pulmozyme® (Genentech) for cystic fibrosis*
- Pulmicort Respules® (AstraZeneca) for asthma*
- TOBI® (Novartis) for cystic fibrosis*
- DuoNeb® (Dey) for COPD, asthma*
- AccuNeb® (Dey) for asthma*
- Perforomist® (Dey) for COPD*
- Xopenex® (Sunovion) for asthma*
- Brovana® (arfomoterol tartate) (Sunovion) for COPD*
- Cayston® (Aztreonam lysine) (Gilead) for cystic fibrosis
- Denufosol tetrasodium (Inspire) for cystic fibrosis
To contact PARI about clinical opportunities, call 1.800.FAST.NEB
* All registered marks and trademarks belong to their respective companies.